Provectus Biopharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $697.5K
Liabilities Breakdown FY2025
Total Liabilities: $7.0M
Asset Breakdown
Total Assets: $697.5K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $251.3K | 36.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.0K | 0.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $443.2K | 63.5% |
Liabilities Breakdown
Total Liabilities: $7.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $716.2K | 10.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.3M | 89.8% |